Effect of high-dose chemotherapy |HDC| on engraftment in dependence on the time of transplantation

被引：0
|
作者：
Hansz, J [1 ]
Kozlowska-Skrzypczak, M [1 ]
机构：
[1] Univ Med Sci, Poznan, Poland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1998年 / 102卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：207 / 207
页数：1
相关论文
共 50 条
  • [1] High-dose chemotherapy (HDC) & autologous PBPC transplantation in the adjuvant treatment of high risk breast cancer
    Constenla, M
    Lorenzo, I
    Rey, C
    Carrete, N
    Campos, B
    Arroyo, FR
    Ozores, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S38 - S38
  • [2] HIGH-DOSE CHEMOTHERAPY (HDC) FOLLOWED BY STEM CELL TRANSPLANTATION (SCT) IN POOR PROGNOSIS BRAIN TUMORS
    Messina, G.
    Quartarone, E.
    Pucci, G.
    Console, G.
    Irrera, G.
    Martino, M.
    Callea, I.
    Pontari, A.
    Ronco, F.
    Penna, G.
    Mandaglio, R.
    Odantini, R.
    Pensabene, V.
    Gangemi, A.
    Cafarelli, F.
    Morabito, F.
    Iacopino, P.
    ANNALS OF ONCOLOGY, 2004, 15 : 83 - 83
  • [3] Effect of GCSF on LDH and LFT's in patients undergoing high-dose chemotherapy (HDC) and hematopoietic stem cell transplantation (HSCT).
    Shannon, KJ
    Tabbara, IA
    BLOOD, 1999, 94 (10) : 325B - 325B
  • [4] High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
    A Sauerbrey
    S Bielack
    B Kempf-Bielack
    A Zoubek
    M Paulussen
    F Zintl
    Bone Marrow Transplantation, 2001, 27 : 933 - 937
  • [5] High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
    Sauerbrey, A
    Bielack, S
    Kempf-Bielack, B
    Zoubek, A
    Paulussen, M
    Zintl, F
    BONE MARROW TRANSPLANTATION, 2001, 27 (09) : 933 - 937
  • [6] High-dose chemotherapy with peripheral blood stem cell transplantation (HDC/PBSCT) for mantle cell lymphoma (MCL).
    Frakes, L
    Miller, W
    McMillan, R
    Meisenberg, B
    BLOOD, 1996, 88 (10) : 3859 - 3859
  • [7] Societal costs of high-dose chemotherapy (HDC) in women with breast cancer.
    Yee, GC
    Hui, JW
    Seifeldin, RA
    Boyette, R
    Weeks, FM
    Wingard, JR
    BLOOD, 1998, 92 (10) : 279A - 279A
  • [8] Analysis of pulmonary infections during high-dose chemotherapy (HDC) and peripheral blood stem cell autologous transplantation (PBSCT)
    Sola, C
    Salazar, R
    Maroto, P
    Tabernero, JM
    Valenti, V
    Brunet, J
    Ojeda, B
    Alonso, MC
    Verger, G
    Lopez, JJL
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 421 - 421
  • [9] High-dose chemotherapy (HDC) with stemcell rescue for patients with metastatic Ewing's sarcoma
    Nooy, MA
    Fibbe, W
    Ouwerkerk, J
    vanBenthem, D
    Noordijk, EM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1202 - 1202
  • [10] Population pharmacokinetics (PK) of thiotepa (TT) and tepa (T) in high-dose chemotherapy (HDC).
    Huitema, ADR
    Mathôt, RAA
    Tibben, MM
    Schellens, JHM
    Rodenhuis, S
    Beijnen, JH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 101 - 101
12345